Blog

Levaquin (also known as levofloxacin) is a popular antibiotic that has been used for years for the treatment of upper respiratory infections, urinary tract infections, prostatitis, and bacterial infections.  It is part of a class of drugs known as fluoroquinolones, which were first marketed in the United States in 1997.  […]

Merck’s nightmare over Vioxx continues.  This is one that has cost the company dearly – on Wall Street, among physicians, in scientific circles, in the judicial system, and in the court of public opinion.  The latest blow came from the New England Journal of Medicine which published additional information regarding […]

A novel lawsuit is winding its way through the courts in St. Louis.  Thirty Missouri hospitals are pursuing claims against Altria (the parent company of Phillip Morris) and other tobacco manufacturers for the costs of medical care provided to patients with tobacco-induced diseases who were uninsured or unable to pay […]

A recent study published in Kidney International, the journal of the International Society of Nephrology, noted increasing concerns over the use of gadolinium-based contrast agents in patients with renal or liver disease.  In this article, researchers from the Oregon Health and Science University urged the use of ultrasmall superparamagnetic iron […]